 The Company is currently evaluating several strategic options in order to determine the best path forward. Following the receipt of warrant exercise proceeds, the Company believes it will have sufficient cash to fund its planned operations through this evaluation process. In addition, the Company has received the full data package for this study and is now working on the De Novo application. 